-
Citizens Reiterates Market Outperform on Ideaya Biosciences (IDYA); Bullish on Darovasertib
-
Citizens stays bullish on Ideaya ahead of ESMO update
-
Citizens JMP Reiterates Market Outperform Rating on Ideaya Biosciences (IDYA)
-
Citizens JMP Starts Ideaya Biosciences (IDYA) at Market Outperform
-
IDEAYA Biosciences Announces Participation in Upcoming December 2024 Investor Relations Events
-
Citi Reiterates Buy Rating on Ideaya Biosciences (IDYA)
-
Citi Reiterates Buy Rating on Ideaya Biosciences (IDYA)
-
Ideaya Biosciences (IDYA) PT Raised to $60 at Citi, 'still believe IDYA remains an attractive M&A target'
-
Ideaya Biosciences (IDYA) Mentioned Positively at Citi, 'developing into an attractive takeout candidate'
-
Citi Shuffles North American Focus List Names
-
IDEAYA Biosciences to Participate in Upcoming September 2023 Investor Relations Events
-
IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
-
IDEAYA Biosciences (IDYA) Prices 7.44M Share Offering at $18.50/sh
-
IDEAYA Announces Pricing of Public Offering
-
IDEAYA Biosciences (IDYA) Announces $150M Proposed Public Offering of Common Stock
-
IDEAYA Announces Proposed Public Offering of Common Stock
-
IDEAYA Biosciences to Participate in Citi's 2023 Virtual Oncology Leadership Summit
-
IDEAYA Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
IDEAYA Biosciences (IDYA) Prices 7.62M Share Offering at $10.50/sh
-
IDEAYA Announces Pricing of Public Offering of Common Stock
-
IDEAYA Biosciences (IDYA) Announces $80M Proposed Public Offering of Common Stock
-
IDEAYA Announces Proposed Public Offering of Common Stock
-
IDEAYA Biosciences to Participate in Investor Conferences in September 2022
-
IDEAYA Biosciences to Participate in Investor Conferences in May 2022
-
IDEAYA Biosciences to Participate in Investor Conferences in September 2021
-
IDEAYA Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
IDEAYA Announces Pricing of Public Offering of Common Stock
-
IDEAYA Biosciences (IDYA) Announces $80M Proposed Public Offering of Common Stock
-
IDEAYA Announces Proposed Public Offering of Common Stock
-
IDEAYA to Participate in Upcoming March 2021 Investor Relations Events
-
Pre-Open Stock Movers 07/13: (BFYT) (ALT) (TSLA) Higher; (CLSN) Lower (more...)
-
IDEAYA Biosciences (IDYA) Prices 6.67M Share Common Offering at $15/Sh
-
IDEAYA Announces Pricing of Public Offering of Common Stock
-
IDEAYA Biosciences (IDYA) Announces $60M Proposed Public Offering of Common Stock
-
IDEAYA Announces Proposed Public Offering of Common Stock
-
Citi Starts Ideaya Biosciences (IDYA) at Buy
-
IDEAYA Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
IDEAYA Biosciences Inc. (IDYA) Prices 5M Share IPO at $10/Sh
-
IDEAYA Announces Pricing of Initial Public Offering

